` Comparison: VX1 vs PNEXF - Alpha Spread

VX1
vs
PNEXF

Over the past 12 months, VX1 has outperformed PNEXF, delivering a return of -11% compared to the PNEXF's 0% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
VX1
PNEXF
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

VX1 Intrinsic Value
HIDDEN
Show
PNEXF Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Vertex Pharmaceuticals Inc
F:VX1
400.75 EUR
Pharnext SCA
OTC:PNEXF
999 999.9999 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
VX1, PNEXF

VX1
PNEXF
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Vertex Pharmaceuticals Inc
Revenue
Pharnext SCA
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
VX1, PNEXF

VX1
PNEXF
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Vertex Pharmaceuticals Inc
F:VX1
Pharnext SCA
OTC:PNEXF
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

VX1
86.3%
PNEXF
0%

Operating Margin

VX1
38.7%
PNEXF
-17 526.7%

Net Margin

VX1
31.3%
PNEXF
-21 040%

FCF Margin

VX1
28.5%
PNEXF
-15 953.3%

ROE

VX1
22.3%
PNEXF
114.6%

ROA

VX1
15.6%
PNEXF
-391.1%

ROIC

VX1
25.1%
PNEXF
3 092.9%

ROCE

VX1
23.5%
PNEXF
275.4%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
VX1, PNEXF

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
VX1, PNEXF

Performance Gap Between VX1 and PNEXF
HIDDEN
Show

Performance By Year
VX1, PNEXF

Loading
VX1
PNEXF
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare VX1 to other stocks
MRK
Merck & Co Inc
GILD
Gilead Sciences Inc
BMY
Bristol-Myers Squibb Co
REGN
Regeneron Pharmaceutical...
Custom
Choose any stock
Unlock Full Access to Alpha Spread
Create Free Account